Grantham, Mayo, Van Otterloo & Co (GMO)
MEDP icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Medpace MEDP Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18M Buy
+34,060
New +$15.7M 0.04% 196
2025
Q4 		– Sell
-34,097
Closed -$17.5M – 685
2025
Q3 		$17.5M Buy
34,097
+319
+0.9% +$139K 0.05% 184
2025
Q2 		$10.6M Buy
33,778
+11,768
+53% +$3.53M 0.03% 226
2025
Q1 		$6.71M Buy
22,010
+4,818
+28% +$1.62M 0.02% 277
2024
Q4 		$5.71M Buy
+17,192
New +$5.83M 0.02% 293
2024
Q3 		– Sell
-38,237
Closed -$15.7M – 582
2024
Q2 		$15.7M Buy
38,237
+3,432
+10% +$1.36M 0.05% 229
2024
Q1 		$14.1M Sell
34,805
-16,760
-33% -$5.89M 0.05% 228
2023
Q4 		$15.8M Sell
51,565
-2,444
-5% -$660K 0.07% 198
2023
Q3 		$13.1M Buy
54,009
+8,635
+19% +$2.21M 0.06% 228
2023
Q2 		$10.9M Buy
+45,374
New +$9.43M 0.05% 250
2019
Q1 		– Sell
-12,500
Closed -$662K – 725
2018
Q4 		$662K Hold
12,500
– – 0.01% 402
2018
Q3 		$749K Sell
12,500
-6,800
-35% -$372K 0.01% 404
2018
Q2 		$830K Buy
19,300
+700
+4% +$28.3K 0.01% 384
2018
Q1 		$649K Buy
+18,600
New +$680K ﹤0.01% 438

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MEDP Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Medpace (MEDP) in Q2 2026: 34,060 shares worth $18M. The stake represents 0.04% of the portfolio and ranks #196 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in MEDP as recently as Q3 2025.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MEDP in Q1 2018 and has held it in 14 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 34,060 shares of Medpace worth $18M as of Q2 2026.
  • Medpace was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q2 2026.
  • Medpace made up 0.04% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #196 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Medpace in Q1 2018 and has held it in 14 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.